These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 23451743
1. Making the diagnosis of frontotemporal lobar degeneration. Bigio EH. Arch Pathol Lab Med; 2013 Mar; 137(3):314-25. PubMed ID: 23451743 [Abstract] [Full Text] [Related]
2. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Seo SW, Thibodeau MP, Perry DC, Hua A, Sidhu M, Sible I, Vargas JNS, Gaus SE, Rabinovici GD, Rankin KD, Boxer AL, Kramer JH, Rosen HJ, Gorno-Tempini ML, Grinberg LT, Huang EJ, DeArmond SJ, Trojanowski JQ, Miller BL, Seeley WW. Neurology; 2018 Mar 20; 90(12):e1047-e1056. PubMed ID: 29453245 [Abstract] [Full Text] [Related]
3. Plasma proteome profiling identifies changes associated to AD but not to FTD. Mofrad RB, Del Campo M, Peeters CFW, Meeter LHH, Seelaar H, Koel-Simmelink M, Ramakers IHGB, Middelkoop HAM, De Deyn PP, Claassen JAHR, van Swieten JC, Bridel C, Hoozemans JJM, Scheltens P, van der Flier WM, Pijnenburg YAL, Teunissen CE. Acta Neuropathol Commun; 2022 Oct 22; 10(1):148. PubMed ID: 36273219 [Abstract] [Full Text] [Related]
4. Frontotemporal lobar degeneration: diversity of FTLD lesions. Seilhean D, Bielle F, Plu I, Duyckaerts C. Rev Neurol (Paris); 2013 Oct 22; 169(10):786-92. PubMed ID: 24035575 [Abstract] [Full Text] [Related]
8. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration. Kobayashi Z, Arai T, Kawakami I, Yokota O, Hosokawa M, Oshima K, Niizato K, Shiraishi A, Akiyama H, Mizusawa H. Psychogeriatrics; 2018 Jul 22; 18(4):307-312. PubMed ID: 30133939 [Abstract] [Full Text] [Related]
9. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. Seltman RE, Matthews BR. CNS Drugs; 2012 Oct 01; 26(10):841-70. PubMed ID: 22950490 [Abstract] [Full Text] [Related]
10. [Magnetic resonance imaging for frontotemporal lobar degeneration]. Oba H, Tokumaru A. Brain Nerve; 2009 Nov 01; 61(11):1269-73. PubMed ID: 19938683 [Abstract] [Full Text] [Related]
17. Novel CSF biomarkers for frontotemporal lobar degenerations. Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Neurology; 2010 Dec 07; 75(23):2079-86. PubMed ID: 21048198 [Abstract] [Full Text] [Related]
18. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW. Neurology; 2006 Jan 10; 66(1):41-8. PubMed ID: 16401843 [Abstract] [Full Text] [Related]
19. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau). Gibbons GS, Kim SJ, Robinson JL, Changolkar L, Irwin DJ, Shaw LM, Lee VM, Trojanowski JQ. Acta Neuropathol Commun; 2019 Mar 04; 7(1):34. PubMed ID: 30832741 [Abstract] [Full Text] [Related]
20. Frontotemporal lobar degeneration in the "Annual of the Pathological Autopsy Cases in Japan". Horimoto Y, Sato C, Suzuki A, Inagaki A, Tajima T, Hibino H, Inagaki H. J Neurol; 2024 Aug 04; 271(8):5549-5555. PubMed ID: 38909120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]